Cambridge Nutritional Sciences (FRA:RVKA) EPS without NRI: €-0.00 (TTM As of Sep. 2025)


What is Cambridge Nutritional Sciences EPS without NRI?

Cambridge Nutritional Sciences FRA:RVKA EPS without NRI is €-0.00 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 88.82% on this metric.

Cambridge Nutritional Sciences's earnings per share without non-recurring items for the six months ended in Sep. 2025 was €-0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was €-0.00.

During the past 12 months, Cambridge Nutritional Sciences's average earnings per share (NRI) Growth Rate was -200.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 50.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Cambridge Nutritional Sciences's EPS without NRI or its related term are showing as below:

FRA:RVKA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -38.7   Med: -20.75   Max: 50
Current: 50

During the past 13 years, Cambridge Nutritional Sciences's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 50.00% per year. The lowest was -38.70% per year. And the median was -20.75% per year.

FRA:RVKA's 3-Year EPS without NRI Growth Rate is ranked better than
88.82% of 662 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs FRA:RVKA: 50.00

Cambridge Nutritional Sciences's EPS (Diluted) for the six months ended in Sep. 2025 was €-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €0.01.

Cambridge Nutritional Sciences's EPS (Basic) for the six months ended in Sep. 2025 was €-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 was €0.01.


Cambridge Nutritional Sciences  (FRA:RVKA) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cambridge Nutritional Sciences EPS without NRI Related Terms


Cambridge Nutritional Sciences EPS without NRI Historical Data

* Premium members only.

The historical data trend for Cambridge Nutritional Sciences's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambridge Nutritional Sciences EPS without NRI Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.01 -0.01 0.00 -0.00

Cambridge Nutritional Sciences Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 -0.00 0.00 -0.00

FRA:RVKA vs ISRG, BDX, MDLN: EPS without NRI Comparison

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's PE Ratio without NRI falls into.



Cambridge Nutritional Sciences EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-0.00 mean?
Cambridge Nutritional Sciences (FRA:RVKA) has a EPS without NRI of €-0.00 as of Sep. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cambridge Nutritional Sciences and its competitors. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #74 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 11.2%.
Is Cambridge Nutritional Sciences' EPS without NRI too high?
Cambridge Nutritional Sciences' current EPS without NRI is €-0.00. Based on the distribution chart, Cambridge Nutritional Sciences ranks #74 out of 662 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Cambridge Nutritional Sciences' EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #74 out of 662 companies for EPS without NRI. This places Cambridge Nutritional Sciences in the top 11% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current EPS without NRI is €-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current EPS without NRI of €-0.00. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 30% below its estimated fair value. The current EPS without NRI is €-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current EPS without NRI is €-0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cambridge Nutritional Sciences Business Description

Other Exchanges CNSL:UK
Address One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.